Patients With Myelodysplastic Syndromes Benefit From Therapy With Amifostine Pentoxifylline and Ciprofloxacin With Dexamethasone.

gdc.relation.journal Blood en_US
dc.contributor.author Turken, Orhan
dc.contributor.author Orhan, Betül
dc.contributor.author Öztürk, Ahmet
dc.contributor.author Etiz, Durmuş
dc.contributor.author Yaylacı, Mustafa
dc.contributor.author Uskent, Necdet
dc.contributor.other Core Program
dc.contributor.other 07. Core Program
dc.contributor.other 01. Kadir Has University
dc.date.accessioned 2019-06-27T08:01:03Z
dc.date.available 2019-06-27T08:01:03Z
dc.date.issued 2001
dc.description.abstract [Abstract Not Available] en_US]
dc.identifier.citationcount 0
dc.identifier.issn 0006-4971 en_US
dc.identifier.issn 0006-4971
dc.identifier.uri https://hdl.handle.net/20.500.12469/232
dc.language.iso en en_US
dc.publisher Amer Soc Hematology en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.title Patients With Myelodysplastic Syndromes Benefit From Therapy With Amifostine Pentoxifylline and Ciprofloxacin With Dexamethasone. en_US
dc.type Conference Object en_US
dspace.entity.type Publication
gdc.author.institutional Öztürk, Ahmet Sertaç
gdc.coar.access metadata only access
gdc.coar.type text::conference output
gdc.description.endpage 276B
gdc.description.issue 11
gdc.description.publicationcategory Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı en_US
gdc.description.startpage 276B en_US
gdc.description.volume 98 en_US
gdc.description.wosquality Q1
gdc.identifier.wos WOS:000172134201254 en_US
gdc.wos.citedcount 0
relation.isAuthorOfPublication 509a54c0-1a22-4f10-b3ce-a6130c3c8845
relation.isAuthorOfPublication.latestForDiscovery 509a54c0-1a22-4f10-b3ce-a6130c3c8845
relation.isOrgUnitOfPublication 0829c741-cc05-42c7-934e-943f8448105f
relation.isOrgUnitOfPublication 6389da7e-5f65-438e-aceb-644a52934d07
relation.isOrgUnitOfPublication b20623fc-1264-4244-9847-a4729ca7508c
relation.isOrgUnitOfPublication.latestForDiscovery 0829c741-cc05-42c7-934e-943f8448105f

Files